Summit Global Investments - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 162 filers reported holding ANTARES PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2021$485,000
-4.5%
133,200
+14.3%
0.04%
+20.0%
Q2 2021$508,000116,5000.03%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,055,0004.58%
Centric Wealth Management 3,337,449$13,717,0003.92%
Sargent Investment Group, LLC 3,599,580$14,794,0003.90%
Rubric Capital Management LP 8,722,647$35,850,0002.09%
PERKINS CAPITAL MANAGEMENT INC 542,283$2,229,0001.29%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$7,809,0001.17%
Venator Capital Management Ltd. 550,000$2,624,0000.89%
LEVEL FOUR FINANCIAL, LLC 120,000$493,0000.23%
ALGERT GLOBAL LLC 147,616$607,0000.19%
Brown Advisory Securities, LLC 275,000$1,130,0000.19%
View complete list of ANTARES PHARMA INC shareholders